Mark Corrigan Nabriva Therapeutics PLC (NBRV) insider trading activity

NBRV Quotes by TradingView

Mark Corrigan is Director of Nabriva Therapeutics plc. Currently has a direct ownership of 7,203 shares of NBRV, which is worth approximately $2,881. The most recent transaction as insider was on Aug 02, 2022, when has been sold 10,297 shares (Ordinary Shares) at a price of $0.19 per share, resulting in proceeds of $1,956. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 7.2K
0% 3M change
0% 12M change
Total Value Held $2,881

MARK CORRIGAN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 02 2022
SELL
Open market or private sale
$1,956 $0.19 p/Share
10,297 Reduced 58.84%
7,203 Ordinary Shares
Jul 28 2021
BUY
Grant, award, or other acquisition
-
17,500 Added 50.0%
17,500 Ordinary Shares

Also insider at

WVE
Wave Life Sciences Ltd. Healthcare
TRVN
TREVENA INC Healthcare
Director
MC

Mark Corrigan

Director
Fort Washington, PA

Track Institutional and Insider Activities on NBRV

Follow Nabriva Therapeutics plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NBRV shares.

Notify only if

Insider Trading

Get notified when an Nabriva Therapeutics PLC insider buys or sells NBRV shares.

Notify only if

News

Receive news related to Nabriva Therapeutics plc

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on NBRV